Orion Portfolio Solutions LLC Purchases 5,447 Shares of Zoetis Inc. (NYSE:ZTS)

Orion Portfolio Solutions LLC boosted its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 9.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 64,932 shares of the company's stock after purchasing an additional 5,447 shares during the period. Orion Portfolio Solutions LLC's holdings in Zoetis were worth $10,579,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the company. Howard Capital Management Group LLC boosted its holdings in Zoetis by 0.8% during the third quarter. Howard Capital Management Group LLC now owns 104,866 shares of the company's stock worth $20,489,000 after buying an additional 883 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Zoetis by 17.3% during the 3rd quarter. Principal Financial Group Inc. now owns 2,377,403 shares of the company's stock worth $464,497,000 after acquiring an additional 351,372 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of Zoetis by 383.1% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 67,517 shares of the company's stock worth $13,191,000 after acquiring an additional 53,540 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Zoetis by 8.7% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 204,920 shares of the company's stock worth $40,037,000 after purchasing an additional 16,421 shares during the period. Finally, Vinva Investment Management Ltd lifted its holdings in shares of Zoetis by 8.2% during the third quarter. Vinva Investment Management Ltd now owns 19,456 shares of the company's stock valued at $3,790,000 after purchasing an additional 1,467 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Activity at Zoetis

In other Zoetis news, EVP Roxanne Lagano sold 326 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $170.00, for a total value of $55,420.00. Following the sale, the executive vice president now owns 15,781 shares of the company's stock, valued at $2,682,770. This trade represents a 2.02 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Willie M. Reed sold 1,210 shares of the company's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $166.14, for a total transaction of $201,029.40. Following the transaction, the director now owns 11,245 shares of the company's stock, valued at approximately $1,868,244.30. The trade was a 9.71 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,862 shares of company stock valued at $312,254. Corporate insiders own 0.16% of the company's stock.

Zoetis Stock Up 0.7 %

Shares of Zoetis stock traded up $1.16 during trading on Wednesday, hitting $163.07. 695,770 shares of the stock traded hands, compared to its average volume of 2,971,813. The company has a fifty day moving average price of $166.26 and a two-hundred day moving average price of $174.05. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $200.33. The stock has a market cap of $73.02 billion, a P/E ratio of 29.81, a PEG ratio of 2.78 and a beta of 0.94. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75.

Zoetis (NYSE:ZTS - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $1.40 EPS for the quarter, topping the consensus estimate of $1.37 by $0.03. The company had revenue of $2.32 billion during the quarter, compared to the consensus estimate of $2.30 billion. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. Equities research analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date is Monday, April 21st. Zoetis's dividend payout ratio is 36.56%.

Analysts Set New Price Targets

ZTS has been the topic of several recent analyst reports. Stifel Nicolaus cut their price objective on Zoetis from $210.00 to $180.00 and set a "buy" rating on the stock in a report on Tuesday, January 7th. UBS Group assumed coverage on shares of Zoetis in a research report on Monday, December 9th. They issued a "neutral" rating and a $196.00 price target for the company. Barclays lifted their price objective on shares of Zoetis from $242.00 to $244.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. StockNews.com upgraded Zoetis from a "hold" rating to a "buy" rating in a report on Friday, March 7th. Finally, Piper Sandler lifted their price target on Zoetis from $200.00 to $205.00 and gave the company an "overweight" rating in a report on Thursday, February 27th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average target price of $215.90.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.